American Access Care sold to to Fresenius Medical Care

TA Associates, a leading global growth private equity firm, today announced the sale of its portfolio company American Access Care (AAC) to Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME, New York Stock Exchange: FMS). AAC is a rapidly growing operator of outpatient vascular access centers serving individuals with end-stage renal disease (ESRD), commonly known as kidney failure. Fresenius Medical Care is the world's leading company devoted to patient-oriented renal therapy. TA completed a $130 million minority leveraged recapitalization of AAC in October 2006. The company is based in Glen Rock, Pennsylvania.

“This is a very strategic combination of two of the most forward thinking companies in the healthcare delivery marketplace.”

"TA Associates is very pleased to have been associated with AAC during a remarkable growth period," said David S. B. Lang, an Advisor at TA Associates who was on the Board of American Access Care. "This is a very strategic combination of two of the most forward thinking companies in the healthcare delivery marketplace."

"In addition to a flexible financial structure, TA provided the strategic guidance and network of contacts to facilitate our growth," said Raymond Figueroa, Chief Executive Officer of American Access Care. "It has been a pleasure working with such talented and experienced investors."

TA Associates has more than four decades of investing experience, focusing on profitable growth companies. TA's prior investments in the healthcare sector include Alere Medical, Amann Girrbach, AmeriChoice, CompBenefits, Dr Lal PathLabs, Invitrogen, MedSolutions, Millennium Laboratories, MQ Associates, National Imaging Associates, Triumph HealthCare and Twin Med.

"During five years as a TA portfolio company, AAC grew from 14 to 29 freestanding interventional centers and increased procedure volumes by over 4x," said Todd R. Crockett, a Managing Director at TA Associates who was also on the Board of American Access Care. "It has been gratifying to play a part in such significant growth, and we wish Ray, the management team and the AAC Board much continued success."